Reaction
Congenital Nose Malformation reporting signals
As of the last recalculation, Congenital Nose Malformation appears in 530 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is VALPROATE SODIUM (PRR 145.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Valproate Sodium | 67 | 145.6 | 146.1 |
| Valproic Acid | 77 | 112.1 | 112.4 |
| Lopinavir And Ritonavir | 16 | 47.8 | 47.8 |
| Nevirapine | 10 | 44.3 | 44.4 |
| Misoprostol | 9 | 36.9 | 36.9 |
| Atazanavir | 8 | 22.2 | 22.2 |
| Phenobarbital | 8 | 22.0 | 22.0 |
| Efavirenz | 6 | 21.4 | 21.4 |
| Tenofovir Disoproxil Fumarate Tablets | 4 | 18.3 | 18.3 |
| Vigabatrin | 5 | 13.6 | 13.6 |
| Isotretinoin | 13 | 10.6 | 10.6 |